Table 3.
Author, year [reference] | Population | Exposure | Group | n | Mean1 | SD | P2 |
Secreto, 1983 [21] | Postmenopausal women | Serum T | Controls | 30 | 310 | 110 | |
Carcinoma | 28 | 550 | 200 | 0.001 | |||
Secreto, 1983 [26] | Premenopausal women | Urinary T | Controls | 22 | 6.25 | 3.48 | |
Familiality | 21 | 5.41 | 3.60 | NS | |||
Hyperplasia | 39 | 6.97 | 4.44 | NS | |||
Carcinoma | 18 | 11.3 | 6.78 | 0.01 | |||
Secreto, 1984 [27] | Premenopausal women | Serum T | Controls | 55 | 470 | 160 | |
Breast Hyperplasia | 31 | 550 | 200 | <0.05 | |||
Breast Cancer | 23 | 620 | 220 | <0.005 | |||
Hill, 1985 [22] | Postmenopausal women | Serum T | Healthy Caucasian | 43 | NS | ||
Healthy Japanese | 59 | NS | 0.01 | ||||
Cases Japanese | 33 | NS3 | 0.01 | ||||
Adlercreutz, 1989 [23] | Postmenopausal women | Serum T | Vegetarians | 10 | 172.80 | 86.40 | |
Omnivores | 9 | 233.28 | 66.24 | <0.05 | |||
Cases | 8 | 319.68 | 132.48 | <0.05 |
1Serum T converted to pg/ml and urinary T converted to μg/24 hours. 2Comparisons with mean levels in controls using the t-test. 3Comparison with healthy Japanese group. SD, standard deviation; T, testosterone.